AI assistant
10x Genomics, Inc. — Director's Dealing 2021
Apr 27, 2021
31830_dirs_2021-04-27_ad75d5d4-c892-4670-9847-a6623720eedf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-04-23
Reporting Person: Kosaraju Sridhar (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-23 | Class A Common Stock | S | 100 | $190.05 | Disposed | 16400 | Indirect |
| 2021-04-23 | Class A Common Stock | S | 300 | $191.71 | Disposed | 16100 | Indirect |
| 2021-04-23 | Class A Common Stock | S | 400 | $193.1138 | Disposed | 15700 | Indirect |
| 2021-04-23 | Class A Common Stock | S | 600 | $193.976 | Disposed | 15100 | Indirect |
| 2021-04-23 | Class A Common Stock | S | 100 | $194.74 | Disposed | 15000 | Indirect |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust.
F2: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust").
F3: This transaction was executed in multiple trades at prices ranging from $191.50 to $192.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4: This transaction was executed in multiple trades at prices ranging from $192.66 to $193.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5: This transaction was executed in multiple trades at prices ranging from $193.72 to $194.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.